Psychotherapeutic Medication Guidelines
- ADHD Medication Guidelines for Children and Adolescents in Children under Age 6 2022 – 2023
- Antipsychotic High Dosing Table for Children and Adolescents 2018 – 2019
- Anxiety Medication Guidelines for Children and Adolescents 2022 – 2023
- Bipolar Disorders Medication Guidelines for Children and Adolescents 2022 – 2023
- Insomnia Disorder Medication Guidelines for Children and Adolescents 2022 – 2023
- Major Depression Medication Guidelines for Children and Adolescents 2022 – 2023
- Monitoring Side-Effects of Antipsychotic Medication in Children and Adolescents 2022 – 2023
- Obsessive-Compulsive Disorder Medication Guidelines for Children and Adolescents 2022 – 2023
- Principles of Practice Regarding the Use of Psychotropic Medication in Children Under Age 6 2022 – 2023
- PTSD Medication Guidelines for Children and Adolescents 2022-2023
- Recommendations on DMDD in Children and Adolescents 2022 – 2023
- Schizophrenia Medication Guidelines for Children and Adolescents 2022 – 2023
- Tic Disorders Medication Guidelines for Children and Adolescents 2018 – 2019
- Treatment of Aggression Medication Guidelines for Children and Adolescents 2022 – 2023
ASD & ID Guidelines
- 2019 Principles of Practice in the Context of ASD & ID
- 2019 Special Considerations in Children under Age 6 with ASD & ID
- 2019 Adverse Effect Management During Atypical Antipsychotic Treatment in Youths with ASD & ID
- 2019 Complementary and Alternative Treatments for Children with ASD
- 2019 Medication Optimization and Deprescribing in Children and Adolescents with ASD & ID
- 2019 Treatment of Aggression in the Context of ASD & ID
- 2019 Treatment of Anxiety in the Context of ASD & ID
- 2019 Treatment of Catatonia in the Context of ASD & ID
- 2019 Treatment of Depression or Bipolar Disorder in the Context of ASD & ID
- 2019 Treatment of Hyperactive, Impulsive, and Inattentive Symptoms in the Context of ASD & ID
- 2019 Treatment of Psychosis in the Context of ASD & ID
- 2019 Treatment of Restricted, Repetitive Behaviors in the Context of ASD & ID
- 2019 Treatment of Sleep Disturbances in the Context of ASD & ID
- 2019 Use of Psychotherapeutic Medications and Routine Monitoring in the Context of ASD & ID